About 454
News
Find a list of 454 Life Sciences™'s press releases below:
Current | 2006 | 2005 | 2004 | 2003 | 2002
This part of our web site contains archival information, which should not be considered current and may no longer be accurate.
- 12/19/2005
454 Life Sciences Initiates Collaborative Research Agreement with the Broad Institute
454 Life Sciences Corporation announced today the initiation of a collaborative research agreement with the Broad Institute. Researchers at the Broad Institute will use 454 Life Sciences' system to conduct disease-related genomic studies. - 12/14/2005
National Center for Genome Resources Selects 454 Life Sciences’ Novel Sequencing Technology to Sequence Genome of Major Fungal Pathogen of Vegetable Crops
454 Life Sciences Corporation has been selected by the National Center for Genome Resources to sequence the major pathogen of vegetable crops, Phytophthora capsici. The 65Mb genome will be sequenced at 454's Measurement Services Center. - 12/7/2005
454 Life Sciences and the Genome Sequencing Center at Washington University School of Medicine in St. Louis Announce Collaborative Research Plan
454 Life Sciences Corporation and the Genome Sequencing Center at Washington University School of Medicine announced a collaborative research plan to sequence disease-causing pathogens and to sequence RNA to analyze gene activity in tissue samples. - 11/9/2005
454 Life Sciences Receives Best of What’s New Award from Popular Science Magazine in Global Competition
Company Honored in Personal Health Category For its Genome Sequencer 20 System - 11/1/2005
454 Life Sciences to Present at the Rodman & Renshaw
454 Life Sciences Corporation today announced that President and Chief Executive Officer, Christopher K. McLeod, will present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference. - 10/25/2005
454 Life Sciences Receives Gold Award from the Wall Street Journal in Global Technology Innovation Competition
Company Honored for its Revolutionary Low-cost Genome Sequencing Method - 10/16/2005
President and CEO of 454 Life Sciences to Participate in
454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), today announced that President and Chief Executive Officer, Christopher K. McLeod, will participate in a panel discussion at BIO InvestorForum 2005. - 10/7/2005
454 Life Sciences and Roche Announce Commercial Launch of
454 Life Sciences to receive $7.5 million from Roche for achieving commercialization milestone - 8/1/2005
454 Life Sciences Publishes Breakthrough Genome Sequencing Technique
Microfabrication Allows Sequencing in Record Time Article Published in Nature July 31 Online Edition - 7/26/2005
454 Life Sciences Receives $11.5 Million in Milestones from Roche
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), today announced the achievement of all initial milestones under their exclusive world-wide agreement with Roche. - 4/25/2005
454 Life Sciences Installs First Genome Sequencing System at the Broad Institute
- Technology allows leading researchers to read genomes up to 100 times faster -